Everest Medicines Limited carries a market capitalization of 10.06B, placing it among publicly traded companies globally.
| Market Cap | 10.06B |
| Enterprise Value | N/A |
Everest Medicines Limited's stock has declined approximately -37.16795% over the past 52 weeks. The 50-day moving average sits at 35.30, while the 200-day moving average is 44.20.
| Beta (5Y) | N/A |
| 52-Week Price Change | -37.16795% |
| 50-Day Moving Average | 35.30 |
| 200-Day Moving Average | 44.20 |
| Average Volume (20 Days) | N/A |